STR

Savage Tooele Railroad Line in Utah Wins Surface Transportation Board Approval

Retrieved on: 
Wednesday, April 3, 2024
Longevity, STR, STB, Union Pacific Railroad, Environmental impact assessment, Transport, Savage, Surface Transportation Board, Environmental analysis, Rail transport by country, Line, Rehabilitation

SALT LAKE CITY, April 03, 2024 (GLOBE NEWSWIRE) -- The Surface Transportation Board (STB) has granted Savage Tooele Railroad Company (STR) the authority to build and operate approximately 11 miles of rail line in Tooele County, Utah, including the rehabilitation of existing track.

Key Points: 
  • SALT LAKE CITY, April 03, 2024 (GLOBE NEWSWIRE) -- The Surface Transportation Board (STB) has granted Savage Tooele Railroad Company (STR) the authority to build and operate approximately 11 miles of rail line in Tooele County, Utah, including the rehabilitation of existing track.
  • The STR rail line will connect to Union Pacific Railroad for tenants of the Lakeview Business Park in Grantsville, Utah, linking supply chains and providing an alternative to truck-only transportation with a more environmentally-friendly option.
  • STR is one of the only new railroads approved in the U.S. this year and one of the first railroads owned and operated by a Utah-headquartered company in the state’s history.
  • “I want to congratulate Savage Tooele Railroad on the approval of their Tooele Valley rail project by the Surface Transportation Board,” said Utah Governor Spencer J. Cox.

The Dawn of a New Trading Era STrade Announces the Launch of STR Token

Retrieved on: 
Wednesday, April 3, 2024
Crypto, Intelligence, Algorithm, Visa, Artificial intelligence, Growth, STR, AI, Cryptocurrency

DILTA technology is the backbone of STrade, utilizing state-of-the-art machine learning algorithms to analyze market trends and optimize trading strategies in real-time.

Key Points: 
  • DILTA technology is the backbone of STrade, utilizing state-of-the-art machine learning algorithms to analyze market trends and optimize trading strategies in real-time.
  • The launch of the STR token is not just a testament to STrade's commitment to innovation but also a gateway for investors to be a part of the future of trading.
  • The launch of STR token is anticipated to herald a new era in trading, where technology and tokenomics come together to empower investors and traders alike.
  • With the STR token, STrade is not just creating a new token; it's crafting the future of trading.

Apple Hospitality REIT Acquires the AC Hotel by Marriott Washington DC Convention Center

Retrieved on: 
Wednesday, March 27, 2024
Lodging, Commercial Building & Real Estate, Destinations, Construction & Property, Vacation, REIT, Travel, Professional Services, Tourist Attractions, Other Travel, Finance, Washington Convention Center, Real estate, Growth, STR, Embassy Suites by Hilton, Walter, Hospitality, Acquisition, Capital One Arena, Investment, Hotel, Government, Motto, LEED

Apple Hospitality REIT, Inc. (NYSE: APLE) (the “Company” or “Apple Hospitality”) today announced the acquisition of the 234-room AC Hotel by Marriott Washington DC Convention Center (the “Hotel”) for approximately $116.8 million, or $499,000 per key.

Key Points: 
  • Apple Hospitality REIT, Inc. (NYSE: APLE) (the “Company” or “Apple Hospitality”) today announced the acquisition of the 234-room AC Hotel by Marriott Washington DC Convention Center (the “Hotel”) for approximately $116.8 million, or $499,000 per key.
  • “We are pleased to expand our portfolio with the acquisition of the AC Hotel Washington DC Convention Center and are thrilled to establish a presence in downtown Washington, D.C., a market we have tracked and wanted to have a presence in for some time,” said Nelson Knight, President, Real Estate and Investments of Apple Hospitality.
  • As we look for and continue to underwrite acquisition opportunities, we are dedicated to pursuing transactions that meaningfully enhance our portfolio and maximize long-term value for our shareholders.”
    The AC Hotel Washington DC Convention Center opened in October 2020 and is located at 601 K Street NW, Washington, D.C.
  • Following the acquisition of the AC Hotel Washington DC Convention Center, the Apple Hospitality hotel portfolio includes 224 hotels with 29,886 guest rooms geographically diversified throughout 37 states and the District of Columbia.

Oxford Nanopore Technologies and SeqOne Partner to Support Interpretation of Nanopore Sequencing in Clinical Use

Retrieved on: 
Monday, March 11, 2024
Health Technology, Technology, Nanotechnology, Pharmaceutical, Oncology, Professional Services, Genetics, Artificial Intelligence, Clinical Trials, Science, Biotechnology, Software, Data Analytics, Health, Research, WGS, Nephrology, APHP, STR, Single-nucleotide polymorphism, Partnership, CFH, Patient, Chelsea Handler, RUO, HPO, Oxford Nanopore Technologies, Thrombotic microangiopathy, Developed country, Nanopore sequencing, Thrombosis, CNV, Pharmaceutical industry

Designed to streamline whole genome variant interpretation at scale, SeqOne DiagAi (RUO) saves time and reduces costs by ranking, shortlisting, and suggesting causative variants with best-in-class accuracy.

Key Points: 
  • Designed to streamline whole genome variant interpretation at scale, SeqOne DiagAi (RUO) saves time and reduces costs by ranking, shortlisting, and suggesting causative variants with best-in-class accuracy.
  • It also enables one-click HPO extraction from clinical notes with the DiagAI Notes2HPO large language model.
  • In the future, the collaboration will deliver other variant interpretation applications addressing the needs of cancer predisposition and somatic analysis.
  • “We are excited to collaborate with SeqOne to provide end-to-end solutions for our customers in rare disease and oncology.

Biktarvy® Demonstrates High Rates of Viral Suppression in People With HIV and Comorbidities

Retrieved on: 
Wednesday, March 6, 2024
Biotechnology, AIDS, Hospitals, Health, Pharmaceutical, ARV, Week, Research, Doctor of Philosophy, CROI, Science, CAPRISA, TLD, Fever, Coinfection, TB, STR, Common, Health care, Organization, DTG, Drug resistance, Genotype, HBV, Fungal infection, Principal, Rifampicin, Seroconversion, Tablet, ALT, TDF, Conference, Safety, Biomarker, Pharmacokinetics, Integrase, Metabolism, Emtricitabine, Aes, Gilead Sciences, MD, FDA, Upper respiratory tract infection, Food, Cell, Risk, Prevalence, COVID-19, Death, Patient, HIV/AIDS, Tuberculosis, INSIGHT, HIV, Vaccine

“People with HIV and comorbid conditions or pre-existing treatment resistance can often face complex and evolving treatment needs.

Key Points: 
  • “People with HIV and comorbid conditions or pre-existing treatment resistance can often face complex and evolving treatment needs.
  • The ALLIANCE trial is the first randomized clinical trial of TAF- vs TDF-based regimens in treatment naïve adults with HIV /HBV coinfection.
  • Additionally, ALLIANCE participants treated with Biktarvy exhibited numerically higher levels of HBV viral suppression and seroconversion.
  • The primary outcome measure is viral suppression rates at Week 24, defined as HIV-1 RNA ˂50 copies/mL.

Gilead to Present Late-Breaking Data and Real-World Evidence Highlighting Innovative Antiviral Portfolio and Research Pipeline at CROI 2024

Retrieved on: 
Monday, February 26, 2024
Biotechnology, FDA, AIDS, Health, Pharmaceutical, Research, Infectious Diseases, Hospitals, Science, COVID-19, Clinical Trials, Senior, Hepatitis B, CROI, Hook effect, RWE, STR, Viral, Virus, DTG, Mortality, Lenacapavir, Hepatitis, HBV, Vesatolimod, Fungal infection, HIV-1, MDR, PWH, HDV, Boxed warning, European, Islatravir, Tablet, European Commission, Liver disease, Omicron, Conference, Safety, ART, Civil service commission, Abstract, Bictegravir, Natural history, Virology, Emtricitabine, Gilead Sciences, MD, Food, Coinfection, Immunodeficiency, European Economic Area, Risk, Prevalence, Dexamethasone, Patient, Tuberculosis, INSIGHT, HIV, Pharmaceutical industry

Outcomes from pipeline research studies will also provide insights into investigational treatment candidates, including the novel combination regimen of lenacapavir plus bictegravir.

Key Points: 
  • Outcomes from pipeline research studies will also provide insights into investigational treatment candidates, including the novel combination regimen of lenacapavir plus bictegravir.
  • Additionally, a late-breaker oral presentation of Week 24 data from the INSIGHT trial evaluating Biktarvy in people with HIV and tuberculosis will be presented.
  • Gilead will present new data evaluating the safety and efficacy of Hepcludex® (bulevirtide) in people living with the coinfections of HIV, hepatitis B (HBV) and hepatitis delta (HDV).
  • Biktarvy combines the novel, unboosted INSTI bictegravir, with the Descovy® (emtricitabine 200 mg/tenofovir alafenamide 25 mg tablets, F/TAF) backbone.

Real Estate Giant CoStar Group Selects Arlington, Va. for Global Headquarters

Retrieved on: 
Wednesday, February 14, 2024
Acquisition, AES, Metro, Restaurant, LoopNet, Commonwealth, Capital improvement plan, Quality of life, George Mason University, RTX, CBRE, Virginia Tech, STR, CoStar Group, CNBC, Workforce, Retail

ARLINGTON, Va. , Feb. 14, 2024 /PRNewswire-PRWeb/ -- CoStar Group, a leading global provider of online real estate marketplaces, information, and analytics in the property markets, has selected Arlington County, Va. for its global headquarters, announced Arlington Economic Development. The real estate giant will relocate to Central Place Tower, a 560,000-square-foot office building in Arlington, Va. in late 2024. CoStar Group will occupy 175,000 square feet of commercial office space and employ 650 workers at the facility, located at 1201 Wilson Boulevard.

Key Points: 
  • The real estate giant will relocate to Central Place Tower, a 560,000-square-foot office building in Arlington, Va. in late 2024.
  • CoStar Group will occupy 175,000 square feet of commercial office space and employ 650 workers at the facility, located at 1201 Wilson Boulevard.
  • CoStar Group joins additional businesses with headquarters of note in Arlington, including AES, Amazon, Boeing, Nestlé and RTX.
  • CoStar Group will pay $13,951,900 to Arlington County to obtain sole use of the observation deck at 1201 Wilson Boulevard.

AirDNA Reveals Top Places to Invest in Short-Term Rentals in 2024

Retrieved on: 
Tuesday, February 6, 2024
Sale, STR, SVP, Commercial property

DENVER, Feb. 6, 2024 /PRNewswire/ -- AirDNA , a leading short-term rental (STR) data and analytics provider, today released its 2024 Best Places to Invest report .

Key Points: 
  • DENVER, Feb. 6, 2024 /PRNewswire/ -- AirDNA , a leading short-term rental (STR) data and analytics provider, today released its 2024 Best Places to Invest report .
  • This essential guide pinpoints the most promising markets for investment this year, identifying U.S. hotspots where investors can maximize returns.
  • The relaunch of the AirDNA product suite has made it easier than ever to customize your search for top markets.
  • AirDNA's Top 10 Places to Invest in 2024:

Auterion Government Solutions Revolutionizes How Combat Forces Leverage Information During Multi-Drone Operations

Retrieved on: 
Tuesday, February 6, 2024
Partnership, Robotics, Defense Innovation Unit, DIU, STR

MOORPARK, Calif., Feb. 6, 2024 /PRNewswire-PRWeb/ -- Auterion Government Solutions, the company that enables the rapid innovation, deployment and evolution of robotics capabilities through the power, flexibility and interoperability of open architecture software, is working with DIU to revolutionize how combat forces harness the wealth of information gained from drones within the operating environment. Known as collaborative autonomy, this capability allows drone operators to decrease their cognitive load while advancing combat effectiveness.

Key Points: 
  • Known as collaborative autonomy, this capability allows drone operators to decrease their cognitive load while advancing combat effectiveness.
  • "Collaborative autonomy will redefine the battlefield and provide end-users with real-time situational awareness like they've never had before," said Errol Farr, President of Auterion Government Solutions.
  • In partnership and under the guidance of the Defense Innovation Unit, Auterion Government Solutions is actively shaping the future of multi-drone operations through strategic partnerships with industry leaders, including Skydio and STR.
  • "Collaborative autonomy will redefine the battlefield and provide end-users with real-time situational awareness like they've never had before," said Errol Farr, President of Auterion Government Solutions.

Choice Hotels Sets the Record Straight on Path to Regulatory Approval of Combination with Wyndham Hotels & Resorts

Retrieved on: 
Wednesday, January 10, 2024
Second request, Choice Hotels, STR, STR1, Wyndham Hotels & Resorts, IHG, Commitment, Goldman Sachs, CHH, Marketing, Wells Fargo, FTC, Hotel

NORTH BETHESDA, Md., Jan. 10, 2024 /PRNewswire/ -- Choice Hotels International, Inc. (NYSE: CHH) (the "Company" or "Choice"), today issued an investor presentation and infographic disputing the false and misleading antitrust claims made by Wyndham Hotels & Resorts, Inc. (NYSE: WH) ("Wyndham") in connection with Choice's proposal to acquire Wyndham. The presentation has been filed with the U.S. Securities and Exchange Commission and is also available at CreateValueWithChoice.com.

Key Points: 
  • Patrick Pacious, President and Chief Executive Officer of Choice Hotels, said, "We are disappointed Wyndham is pushing this disinformation campaign.
  • Their take on the antitrust risk on our proposed combination is misleading and further reflects the board's apparent entrenchment.
  • Wyndham overlooks that Choice and Wyndham account for only 10% of U.S. room revenue.
  • Choice is proceeding along the expected path of regulatory review: Despite Wyndham's refusal to engage, Choice is making progress on the regulatory process with the U.S. Federal Trade Commission ("FTC").